Here, for the first time, we have presented representative data for Croatian patients with lung adenocarcinomas, and we demonstrate a higher prevalence of the specific L858R mutation in the EGFR gene, as well as a higher prevalence of KRAS mutations. Here, EGFR is linked to lung adenocarcinoma.